You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • FRI0100 Determining minimum clinically important change in multi biomarker disease activity score associated with clinical improvement in methotrexate naÏve patients with early rheumatoid arthritis

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
Rheumatoid arthritis - prognosis, predictors and outcome
FRI0100 Determining minimum clinically important change in multi biomarker disease activity score associated with clinical improvement in methotrexate naÏve patients with early rheumatoid arthritis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Chatzidionysiou K, Hensvold A, Saevarsdottir S, et al
FRI0100 Determining minimum clinically important change in multi biomarker disease activity score associated with clinical improvement in methotrexate naÏve patients with early rheumatoid arthritis
Annals of the Rheumatic Diseases 2017;76:517-518.